Year in Review: The Most Popular IP Posts of 2020

Mintz - Intellectual Property Viewpoints
Contact

Mintz - Intellectual Property Viewpoints

As 2021 begins and intellectual property (IP) strategies are being developed for the new year, it is a good time to reflect on what IP issues were prominent in 2020. According to many readers, hot topics included Chinese foreign filing licenses, patenting involving either artificial intelligence (AI) or COVID-19, inter partes review, and attorney fee awards.

Here are 2020’s top 5 most popular Mintz IP posts:

1. Strategic Considerations for Obtaining a Foreign Filing License in China – This article outlines why and when a foreign filing license is needed in China as well as bypass continuations in the U.S. and the use of a PCT request filed in China to obtain a foreign filing license.

2. Patenting Considerations for Artificial Intelligence in Biotech and Synthetic Biology – Part 2: Key Issues in Patent Subject Matter Eligibility – This article provides helpful information on what is meant by Machine Learning as well as an analysis of some real world challenges in patenting AI biotech or synthetic biology inventions.

3. PTAB’s Precedential Opinion Panel Rejects Review Decision Denying Institution Due to Proximity of District Court Trial, and Remands Back to Panel for Supplemental Briefing – In Sand Revolution II, LLC v. Continental Intermodal Group-Trucking LLC, the U.S. Patent Trial and Appeal Board declined to institute an inter partes review (IPR) based on parallel district court action where the jury trial was scheduled to occur prior to the Board’s final written decision. This article discusses the decision and its implications related to how delayed trials can affect IPR petitions.

4. Federal Circuit Awards Attorney Fees to Defendant Following Dismissal of Lawsuit by Plaintiff –This article discusses the Federal Circuit’s decision in Blackbird Tech LLC v. Health in Motion LLC that affirmed a district court award of costs and attorneys’ fees against a non-practicing entity, citing the need “to deter future abusive litigation.”

5. COVID-19: Prioritized Patent Application Examination and Patents 4 Partnerships – This article provides a useful overview of the U.S. Patent and Trademark Office’s 2020 initiatives to support COVID-19 innovations: 1) a COVID-19 Prioritized Examination Pilot Program, and 2) Patents 4 Partnerships that provides a searchable forum to list COVID-19 related published applications and patents available for licensing.

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Mintz - Intellectual Property Viewpoints | Attorney Advertising

Written by:

Mintz - Intellectual Property Viewpoints
Contact
more
less

Mintz - Intellectual Property Viewpoints on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.